DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sawada Y, Yoshikawa T, Ofuji K. , et al.
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients.
OncoImmunology 2016;
5 (05) e1129483
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.